Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Com Stk Usd0.01 [Di/Reg S] (MXCN.LN)

Com Stk Usd0.01 [Di/Reg S] (MXCN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 436,621
  • Shares Outstanding, K 100,434
  • Annual Sales, $ 41,288 K
  • Annual Income, $ -37,923 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 24.19
  • Price/Cash Flow N/A
  • Price/Book 3.50
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings $-0.03 on 11/10/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
680.000 unch
on 02/24/22
775.000 -12.26%
on 02/04/22
-95.000 (-12.26%)
since 01/24/22
3-Month
680.000 unch
on 02/24/22
800.000 -15.00%
on 11/30/21
-120.000 (-15.00%)
since 11/24/21
52-Week
680.000 unch
on 02/24/22
1,025.000 -33.66%
on 10/05/21
-270.000 (-28.42%)
since 02/24/21

Most Recent Stories

More News
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
MaxCyte Announces Retirement of Board Member Art Mandell

MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance

MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics

MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
MaxCyte to Participate in Two Upcoming Investor Conferences

MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
MaxCyte Appoints Cynthia Collins to its Board of Directors

PSTX : 9.50 (-0.63%)
MXCN.LN : 680.000 (unch)
DMTKQ : 0.0001 (-80.00%)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
CERT : 11.66 (-0.85%)
MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024

MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer

MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)
MXCT : 4.94 (+4.00%)
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results

45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md.,...

MXCT : 4.94 (+4.00%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 392.000 (+2.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 680.000
2nd Resistance Point 680.000
1st Resistance Point 680.000
Last Price 680.000
1st Support Level 680.000
2nd Support Level 680.000
3rd Support Level 680.000

See More

52-Week High 1,025.000
Fibonacci 61.8% 893.210
Fibonacci 50% 852.500
Fibonacci 38.2% 811.790
Last Price 680.000
52-Week Low 680.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar